SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

ALNY

ALNYLAM PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 13h ago SEC0001422849-26-000177
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion of this 13G to a 13D, which would signal a shift from passive to activist intent. For now, the filing is a routine passive stake update with no immediate trading implications.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$165.04
T+0 close · Nov 13, 2026 · via day close
Latest settled
−3.22%
T+1 · $159.73
Vs SPY
−1.31%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $165.04entry
  2. T+1 · 21h ago −3.22%α −1.31% · $159.73
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Capital World Investors filed an amended Schedule 13G disclosing a 10.4% passive stake in Alnylam Pharmaceuticals as of September 30, 2026, up from a prior filing. This is a routine update for a large passive holder and does not signal any change in investment intent or control.

Key Financial Metrics

Stake
10.4%
Investor
Capital World Investors
Investor Type
mutual fund

Key Facts

  • Capital World Investors reported beneficial ownership of 13,934,539 shares of Alnylam common stock, representing 10.4% of shares outstanding as of September 30, 2026.
  • The filing is an amendment to Schedule 13G, certifying passive investment intent under Rule 13d-1(b).
  • The stake increased from the prior filing (May 2026), which disclosed a lower percentage but no exact prior figure is stated in this document.
  • The filing was made on November 13, 2026, with a signature date of November 11, 2026.

Financial Impact

Capital World Investors holds 13,934,539 shares, valued at approximately $1.5B based on the $21.4B market cap and 133,875,000 shares outstanding.

ownership percentage

Risk Factors

  • No material risks identified from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (38 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001422849-26-000177
Document: 0001422849-26-000177-index.html0001422849-26-000177
Document: 0001422849-26-000177.txt0001422849-26-000177

Track record

15 reports on ALNY

Performance horizon

1 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +26.35% at T+5 after the Oct 23, 2026 report. 1 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $160.53 Now $159.73 −0.50% settles Nov 23
  2. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $165.50 Now $159.73 −3.49% settles Nov 23
  3. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $165.04 Now $159.73 −3.22% settles Nov 20
  4. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $165.04 Now $159.73 −3.22% settles Nov 20
  5. Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $156.66 to $156.65 Now $159.73 +1.96% ▼ −0.01% −3.30% vs SPY
  6. Nov 5, 202611d ago 8-K Neutral 4/10 Entry $156.66 to $156.65 Now $159.73 +1.96% ▼ −0.01% −3.30% vs SPY
  7. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $165.00 to $155.94 Now $159.73 −3.19% ▼ −5.49% −2.79% vs SPY
  8. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $174.00 to $156.66 Now $159.73 −8.20% ▼ −9.97% −5.24% vs SPY
  9. Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $224.03 to $165.00 Now $159.73 +28.70% ▲ +26.35% +25.79% vs SPY
  10. Aug 17, 202613w ago Court Ruling Neutral 4/10 Entry $228.61 to $240.08 Now $159.73 −30.13% ▲ +5.02% +5.22% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens in 5h 44m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026